Market Research Logo

Vaxeal Holding SA - Product Pipeline Review - 2015

Vaxeal Holding SA - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Vaxeal Holding SA - Product Pipeline Review - 2015’, provides an overview of the Vaxeal Holding SA’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Vaxeal Holding SA’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Vaxeal Holding SA including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Vaxeal Holding SA’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Vaxeal Holding SA’s pipeline products
Reasons to buy
  • Evaluate Vaxeal Holding SA’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Vaxeal Holding SA in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Vaxeal Holding SA’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Vaxeal Holding SA and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Vaxeal Holding SA
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Vaxeal Holding SA and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues


Vaxeal Holding SA Snapshot
Vaxeal Holding SA Overview
Key Information
Key Facts
Vaxeal Holding SA - Research and Development Overview
Key Therapeutic Areas
Vaxeal Holding SA - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Vaxeal Holding SA - Pipeline Products Glance
Vaxeal Holding SA - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Vaxeal Holding SA - Drug Profiles
CBX-1
Product Description
Mechanism of Action
R&D Progress
SVX-1
Product Description
Mechanism of Action
R&D Progress
Vaccine for Oncology
Product Description
Mechanism of Action
R&D Progress
Vaxeal Holding SA - Pipeline Analysis
Vaxeal Holding SA - Pipeline Products by Molecule Type
Vaxeal Holding SA - Dormant Projects
Vaxeal Holding SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Vaxeal Holding SA, Key Information
Vaxeal Holding SA, Key Facts
Vaxeal Holding SA - Pipeline by Indication, 2015
Vaxeal Holding SA - Pipeline by Stage of Development, 2015
Vaxeal Holding SA - Monotherapy Products in Pipeline, 2015
Vaxeal Holding SA - Preclinical, 2015
Vaxeal Holding SA - Discovery, 2015
Vaxeal Holding SA - Pipeline by Molecule Type, 2015
Vaxeal Holding SA - Dormant Developmental Projects,2015
Vaxeal Holding SA, Subsidiaries
List of Figures
Vaxeal Holding SA - Pipeline by Top 10 Indication, 2015
Vaxeal Holding SA - Pipeline by Stage of Development, 2015
Vaxeal Holding SA - Monotherapy Products in Pipeline, 2015
Vaxeal Holding SA - Pipeline by Top 10 Molecule Type, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report